GEISTWERT Rechtsanwälte Lawyers Avvocati

https-www.unifiedpatentcourt.org-en-node-159789-c249a552bc86

Amgen Inc. v. Regeneron Pharmaceuticals Inc.

Datum
2025-11-25
Kammer
Luxembourg (LU)
Verfahrensart
Appeal RoP220.1
Sprache
EN

Metadaten

Fall-IDhttps-www.unifiedpatentcourt.org-en-node-159789-c249a552bc86
Aktenzeichen
Registerzeichen
Entscheidungsreferenz
Schlagwörter
Leitsätze

Dokumente und Volltext

Textextraktion: pypdf | Seiten: 35

1 DECISION of the Court of Appeal of the Unified Patent Court issued on 25 November 2025 concerning appeals in a revocation action and a counterclaim for revocation HEADNOTES Claim interpretation 1. The question of whether conclusions can be drawn from the subject matter of a dependent claim and its features when interpreting the main claim depends on the circumstances of the individual case. If the dependent claim is only adding an additional feature that does not provide a more specific description of the features of the main claim, it generally argues against the possibility of drawing conclusions about the interpretation of the main claim from this dependent claim. 2. When the claims are drafted in ‘medical use -format’, it is an inherent claim feature that the claimed product must be  ...